宜曼達 ILMN 深 滬
等待開盤 03-26 09:30:00 美东时间
126.20
+0.220
+0.17%
華盛通- 最 高128.74
- 今 開126.21
- 成交量 140.86万股
- 最 低 122.04
- 昨 收 125.98
- 總市值 193.09亿
- 52周最高 155.529
- 市盈率 靜 23.16
- 換手率 0.92%
- 52周最低 68.70
- 委 比 -22.70%
- 總股本 1.53亿
- 歷史最高 552.665
- 量 比 0.91
- 振 幅 5.32%
- 歷史最低 22.465
- 每 手 1
- 風險率 21.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Grail upgraded at TD Cowen; says selloff is buying opportunity
Grail (GRAL) shares spiked on Wednesday after TD Cowen upgraded the Galleri cancer test maker to Buy from Hold, citing an attractive buying opportunity following its recent sell-off. The Illumina (ILM...
03-19 01:10
Illumina and Labcorp expand precision oncology testing collaboration
Illumina and Labcorp expand precision oncology testing collaboration Illumina and Labcorp expanded their collaboration to advance precision oncology using next-generation sequencing solutions. The companies plan projects to broaden access to cancer biomarker testing through distributed test offering
03-18 21:20
Illumina And Labcorp Expand Collaboration To Advance Precision Oncology With NGS, Liquid Biopsy And New Distributed Biomarker Testing
Illumina, Inc. (NASDAQ:ILMN) and Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology through innovative
03-18 21:16
GRAIL announces leadership transition
Cancer test developer Grail (GRAL) has named Josh Ofman, the company's president, as its new chief executive officer, effective June 1, 2026, following the retirement of its long-serving CEO, Bob Ragu...
03-13 19:48
Happy Mario Day: March 10 Celebrates Iconic Video Game Character With Movie Sequel Coming Next Month
March 10 marks the celebration of video game character Mario. Here's why and what's next for the iconic Nintendo character.
03-11 03:14
Autonomix Medical Selected for CRT 2026 Best Innovation Competition Oral Presentation
Autonomix Medical Selected for CRT 2026 Best Innovation Competition Oral Presentation Autonomix Medical Inc. will present “Illuminating The Nervous System With Transvascular Precision-guided Technology” in the Best Innovation Competition at Cardiovascular Research Technologies (CRT) 2026 on March 9,
03-05 21:45
Autonomix Medical Selected for Best Innovation Competition at CRT 2026
Autonomix Medical, Inc. (NASDAQ: AMIX), a medical device company, announced that its presentation titled "Illuminating The Nervous System With Transvascular Precision-guided Technology" has been selected for oral presentation in the Best Innovation Competition at Cardiovascular Research Technologies (CRT) 2026. CEO Brad Hauser will deliver the presentation on March 9, 2026. The competition highlights transformative technologies with the potential...
03-05 13:45
Quanterix targets $169M–$174M 2026 revenue with focus on diagnostics and cost synergies
Earnings Call Insights: Quanterix Corporation (QTRX) Q4 2025 Management View Everett Cunningham, President and CEO, introduced himself to investors, emphasizing his background in healthcare and commer...
03-03 17:08
Illumina, Southern Co, Corning, Seagate, Microchip Insider Shifts
Insiders have been trading these 5 stocks: (($ILMN)), (($SO)), (($GLW)), (($STX...
02-28 21:01
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina...
02-27 22:15
